Envestnet Asset Management Inc Aerie Pharmaceuticals Inc Transaction History

Envestnet Asset Management Inc

  • $302 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022
BUY
$4.95 - $9.16 $175,343 - $324,474
35,423 Added 81.51%
78,879 $592,000
Q1 2022

May 04, 2022
BUY
$5.64 - $9.8 $33,772 - $58,682
5,988 Added 15.98%
43,456 $395,000
Q4 2021

Feb 04, 2022
SELL
$7.02 - $13.33 $317,949 - $603,742
-45,292 Reduced 54.73%
37,468 $263,000
Q3 2021

Oct 07, 2021
BUY
$11.32 - $16.63 $185,908 - $273,114
16,423 Added 24.76%
82,760 $943,000
Q2 2021

Aug 04, 2021
SELL
$15.16 - $18.97 $62,186 - $77,814
-4,102 Reduced 5.82%
66,337 $1.06 Million
Q1 2021

May 04, 2021
BUY
$13.12 - $20.9 $97,888 - $155,934
7,461 Added 11.85%
70,439 $1.26 Million
Q4 2020

Feb 02, 2021
BUY
$9.12 - $14.49 $79,553 - $126,396
8,723 Added 16.08%
62,978 $851,000
Q3 2020

Oct 09, 2020
BUY
$10.46 - $14.46 $259,303 - $358,463
24,790 Added 84.13%
54,255 $639,000
Q2 2020

Jul 08, 2020
BUY
$12.0 - $16.13 $188,076 - $252,805
15,673 Added 113.64%
29,465 $435,000
Q1 2020

Apr 23, 2020
BUY
$11.84 - $25.52 $52,285 - $112,696
4,416 Added 47.1%
13,792 $186,000
Q4 2019

Feb 11, 2020
BUY
$17.72 - $25.1 $166,142 - $235,337
9,376 New
9,376 $227,000
Q3 2017

Nov 13, 2017
SELL
$48.6 - $60.1 $20,120 - $24,881
-414 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
414
414 $22,000

Others Institutions Holding AERI

# of Institutions
3
Shares Held
2.4M
Call Options Held
0
Put Options Held
0
View Full List

About AERIE PHARMACEUTICALS INC

AERI Quotes by TradingView
  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email